Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Ausztrália
20 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Adelaide, Ballarat, Melbourne, Perth, Townsville
- Életkor
- 18 év and over
- People
- 1046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347 · EU 2024-515566-13-00 - 2. fázisTaking peopleEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- East Melbourne
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00 - 1/2. fázisTaking peopleDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
- Where
- Nedlands, Richmond
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT07249905 - 3. fázisTaking peopleA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Where
- Auchenflower, Benowa, East Melbourne, Liverpool, Waratah
- Életkor
- 18 év and over
- People
- 904 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091865 · EU 2022-502785-25-00 - 3. fázisTaking peopleA Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Where
- Douglas, Melbourne
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Lyell Immunopharma, Inc.
See details and how to joinNCT07188558 - 2/3. fázisTaking peopleA Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Ballarat, Perth, Townsville
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017 · EU 2022-502646-27-00 - 1. fázisTaking peopleIKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
- Where
- Adelaide, Hobart, Perth, Westmead
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Clayton, Melbourne, Nedlands, Southport
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Brisbane, Melbourne, Randwick
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 2. fázisTaking peopleConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Where
- Auchenflower, Clayton, Fitzroy, Heidelberg, Hobart, Nedlands, Waratah
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Allogene Therapeutics
See details and how to joinNCT06500273 - 1. fázisTaking peopleA Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Where
- Adelaide, Melbourne, Sydney, Woolloongabba
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07195916 · EU 2025-523130-11-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Concord, Fitzroy, Heidelberg, Melbourne, Nedlands, Waratah, West Perth, Woolloongabba
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 1/2. fázisTaking peopleStudy of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Where
- Melbourne, Nedlands, Perth
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Lyell Immunopharma, Inc.
See details and how to joinNCT05826535 - 2. fázisNot yet taking people in AusztráliaRadiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Where
- Bedford Park, Douglas, Heidelberg, Murdoch, Woolloongabba
- Életkor
- 18 év and over
- People
- 40
- Run by
- Olivia Newton-John Cancer Research Institute
See details and how to joinNCT07634289 - No phaseTaking peopleReal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Kingswood, Malvern, Waratah
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759 - 1. fázisTaking peopleA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Where
- Bedford Park, Buderim, Darlinghurst, Southport, Subiaco, Wollongong, Woolloongabba
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- OncoNano Medicine, Inc.
See details and how to joinNCT06022029 - 3. fázisTaking peopleA Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Where
- Albury, Camperdown, Coffs Harbour, Concord, Cudgen, Garran, Hobart, Liverpool, Melbourne, Murdoch, Orange, Perth, Port Macquarie, Randwick, St Leonards, Sunshine Coast, Waratah, Westmead
- Életkor
- 75 év and over
- People
- 300 worldwide
- Run by
- Nordic Lymphoma Group
See details and how to joinNCT04332822 · EU 2022-502887-19-00 - 2. fázisTaking peopleEpcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
- Where
- Melbourne
- Életkor
- 18 év and over
- People
- 39
- Run by
- Australasian Leukaemia and Lymphoma Group
See details and how to joinNCT06287398 - 2. fázisTaking peopleDPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Where
- Adelaide, Melbourne, Westmead
- Életkor
- 18 év and over
- People
- 102 worldwide
- Run by
- ImmunoVaccine Technologies, Inc. (IMV Inc.)
See details and how to joinNCT04920617 - 1/2. fázisTaking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Adelaide, Box Hill, Geelong, Perth
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394